Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma

19 Jul 2016

Abstract excerpt

// Anna Maria Rachiglio 1 , Riziero Esposito Abate 1 , Alessandra Sacco 1 , Raffaella Pasquale 1 , Francesca Fenizia 1 , Matilde Lambiase 1 , Alessandro Morabito 2 , Agnese Montanino 2 , Gaetano Rocco 3 , Carmen Romano 4 , Anna Nappi 4 , Rosario Vincenzo Iaffaioli 4 , Fabiana Tatangelo 5 , Gerardo Botti 5 , Fortunato Ciardiello 6 , Monica R. Maiello 7 , Antonella De Luca 7 , Nicola Normanno 1, 7 1 Laboratory of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27448974
DOI: 10.18632/oncotarget.10704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinomaPMID 27448974Read ↗

Clinical Tumor Sequencing: Opportunities and Challenges for Precision Cancer MedicineSemantic proximity Read ↗

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.Semantic proximity Read ↗

Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice.Semantic proximity Read ↗

Recent advance of next-generation sequencing in patients with lung cancer.Semantic proximity Read ↗

Molecular tests and target therapies in oncology: recommendations from the Italian workshop.Semantic proximity Read ↗

The significance of using liquid biopsy to improve treatment outcomes for metastatic patientsSemantic proximity Read ↗

Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancerSemantic proximity Read ↗

Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control.Semantic proximity Read ↗

Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities.Semantic proximity Read ↗

[Applications and limitations of liquid biopsy : Applications and methodological limitations of cell-free DNA analysis in tumor diagnostics].Semantic proximity Read ↗

Clinical mutational profiling of 1006 lung cancers by next generation sequencingSemantic proximity Read ↗

Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical use.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.